Genetically Proxied Therapeutic Effect of Lipid-Lowering Drugs Use, Breast Cancer, and Endometrial Cancer’s Risk: A Drug Target-Based Mendelian Randomization Study
Chunxiao Dang, Xiaofeng Wang, Pengfei Liu, Jinxing Liu, Xiao Yu · 2024
Read Genetically Proxied Therapeutic Effect of Lipid-Lowering Drugs Use, Breast Cancer, and Endometrial Cancer’s Risk: A Drug Target-Based Mendelian Randomization Study by Chunxiao Dang, Xiaofeng Wang, Pengfei Liu, Jinxing Liu, Xiao Yu (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11614999.txt.
Description
Chunxiao Dang and four co-authors use genetics in 2024 to ask whether cholesterol-lowering drugs change the risk of breast and womb cancers. Ordinary observation studies had looked at the question and disagreed, since people who take these drugs differ from those who do not in many ways.
The team used Mendelian randomization, which treats inherited gene variants as a natural experiment mimicking each drug's target. They checked the results with several statistical methods and stress tests for hidden bias. Genetic answers like these can separate a drug's real effect from the noise of everyday prescribing.
Catalog record
| CREATOR | Chunxiao Dang, Xiaofeng Wang, Pengfei Liu, Jinxing Liu, Xiao Yu |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 27 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |